CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-31 | Manzo Louis Director | Option exercise · Stock Option (Right to Buy) | −12,449 | 0 | ||
| 2022-03-29 | DUNBAR GEORGE W JR Director | Option exercise | +15,455 | $1.39 | $21K | 15,455 |
| 2022-03-29 | DUNBAR GEORGE W JR Director | Shares withheld for taxes | −6,300 | $3.41 | $21K | 9,155 |
| 2022-03-29 | DUNBAR GEORGE W JR Director | Option exercise · Stock Option (Right to Buy) | −15,455 | 0 | ||
| 2022-03-08 | COLLIER EARL M JR Director | Option exercise | +15,455 | $1.39 | $21K | 15,455 |
| 2022-03-08 | COLLIER EARL M JR Director | Option exercise · Stock Option (Right to Buy) | −15,455 | 0 | ||
| 2022-01-03 | Litvack Frank Director | Option exercise | +154,543 | $1.39 | $215K | 174,934 |
| 2022-01-03 | Litvack Frank Director | Shares withheld for taxes | −67,552 | $3.18 | $215K | 107,382 |
| 2022-01-03 | Litvack Frank Director | Option exercise · Stock Option (Right to Buy) | −154,543 | 0 | ||
| 2022-01-03 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +252,250 | 252,250 | ||
| 2022-01-03 | Sabar Karimah Es Director | Grant or award · Stock Option (Right to Buy) | +7,690 | 7,690 | ||
| 2022-01-03 | Musket David B Director | Grant or award · Stock Option (Right to Buy) | +84,080 | 84,080 | ||
| 2022-01-03 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +83,590 | 83,590 | ||
| 2022-01-03 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +63,060 | 63,060 | ||
| 2022-01-03 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +63,060 | 63,060 | ||
| 2022-01-03 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +166,980 | 166,980 | ||
| 2022-01-03 | Krasney Karen EVP, GENERAL COUNSEL | Grant or award · Stock Option (Right to Buy) | +84,080 | 84,080 | ||
| 2022-01-03 | Marban Linda CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +377,830 | 377,830 | ||
| 2021-12-27 | Musket David B Director | Option exercise | +15,455 | $1.39 | $21K | 38,346 |
| 2021-12-27 | Musket David B Director | Option exercise | +20,391 | $1.10 | $22K | 58,737 |
Page 12 of 24 · 468 trades